Skip to main content
Acta Crystallographica Section F: Structural Biology and Crystallization Communications logoLink to Acta Crystallographica Section F: Structural Biology and Crystallization Communications
. 2009 Feb 26;65(Pt 3):267–270. doi: 10.1107/S1744309109002504

Crystallization and preliminary X-ray crystallographic studies of the Z-DNA-binding domain of a PKR-like kinase (PKZ) in complex with Z-DNA

Doyoun Kim a, Hye-Yeon Hwang a, Yang-Gyun Kim b, Kyeong Kyu Kim a,*
PMCID: PMC2650443  PMID: 19255480

The Z-DNA-binding domain of a PKR-like kinase (PKZ) from goldfish was crystallized in complex with d(TCGCGCG)2. The crystals belonged to space group C2 and diffracted to 1.7 Å resolution.

Keywords: PKZ, Z-DNA, Z-DNA recognition, eIF2α kinase

Abstract

PKZ, a PKR-like eIF2α kinase, consists of a Z-DNA-specific binding domain (Zα) and an eIF2α kinase domain. The kinase activity of PKZ is modulated by the binding of Zα to Z-DNA. The mechanisms underlying Z-DNA binding and the subsequent stimulation of PKZ raise intriguing questions. Interestingly, the Z-­DNA-binding domain of PKZ from goldfish (Carassius auratus; caZαPKZ) shows limited sequence homology to other canonical Zα domains, suggesting that it may have a distinct Z-DNA-recognition mode. In this study, the Z-DNA-binding activity and stoichiometry of caZαPKZ were confirmed using circular dichroism (CD). In addition, preliminary X-ray studies of the caZαPKZ–Z-­DNA complex are reported as the first step in the determination of its three-dimensional structure. Bacterially expressed recombinant caZαPKZ was purified and crystallized with Z-DNA at 295 K using the microbatch method. X-ray diffraction data were collected to 1.7 Å resolution with an R merge of 7.4%. The crystals belonged to the monoclinic space group C2, with unit-cell parameters a = 55.54, b = 49.93, c = 29.44 Å, β = 96.5°. Structural analysis of caZαPKZ–Z-­DNA will reveal the binding mode of caZαPKZ to Z-DNA and its relevance to other Z-DNA-binding proteins.

1. Introduction

The downregulation of protein synthesis via phosphorylation of the α subunit of eukaryotic translation initiation factor 2 (eIF2α) is a well established antiviral and antiproliferation mechanism (Proud, 2005). Double-stranded RNA (dsRNA) dependent protein kinase (PKR) is one of four kinases which mediate this phosphorylation in humans (Garcia et al., 2007). PKR, as well as other known eIF2α kinases, is composed of a conserved kinase domain at the C-­terminus and a regulatory domain at the N-terminus. The latter plays a role in the recognition of various environmental signals and the activation of the kinase domain. The phosphorylation activity of PKR is stimulated when it is bound to double-stranded RNA through the RNA-binding domain. Recently, interferon-inducible PKR-like kinases (PKZs) have been identified in fish species (Hu et al., 2004; Rothenburg et al., 2005; Su et al., 2008). The kinase domain of PKZ is highly homologous to that of PKR and it shares common substrates with PKR (Bergan et al., 2008). However, PKZ contains two Z-DNA-binding domains in its N-terminus instead of the dsRNA-binding domain (dsRBD) of PKR and accordingly modulation of its kinase activity is dependent on Z-DNA binding (Bergan et al., 2008). Left-handed Z-­DNA is a higher energy conformation of DNA which is generated as a consequence of negative supercoiling (Liu & Wang, 1987; Her­bert & Rich, 1999). It has also been reported that the formation of Z-­DNA owing to frequent mutations is associated with various genetic diseases (Wang et al., 2006). Zα domains, which have been identified in dsRNA-editing enzyme ADAR1 (Herbert & Rich, 2001), DNA-dependent activator of interferon regulatory factors DAI (Schwartz et al., 2001; Takaoka et al., 2007) and poxvirus virulence factor E3L (Kim et al., 2003), specifically bind to double-stranded nucleotides in left-handed conformations (Rich & Zhang, 2003).

The crystal structures of Zα domains in complex with Z-DNA have been reported for ZαADAR1 (Schwartz et al., 1999), ZαDAI (Schwartz et al., 2001) and ZαE3L (Ha et al., 2004) and they revealed a common typical winged-helix motif. The recognition of Z-DNA is mediated by the recognition of phosphate backbones in zigzag conformation and the syn conformation of guanine. The residues present in the α3 helix and the β-wing region play important roles in Z-DNA recognition as they are involved in direct contacts with phosphate backbones as well as in water-mediated interactions (Schwartz et al., 1999). Furthermore, structural analyses and mutational biochemical studies confirm that minor variations in the sequence of the β-wing region can alter the van der Waals interactions (Schwartz et al., 2001) and Z-DNA stabilization (Quyen et al., 2007). It was found that the Zα domain of PKZ from goldfish (Carassius auratus; caZαPKZ) shares limited sequence homology to other canonical Z-DNA-binding domains. 26% identity is observed between caZαPKZ and hZαADAR1 when 75 residues are compared. Interestingly, the Lys170 residue which plays a critical role in Z-DNA recognition is not present in caZαPKZ. Thus, very intriguing questions arise of how caZαPKZ recognizes Z-DNA and consequently how Z-DNA binding modulates the kinase activity of PKZ. Structural study of caZαPKZ is required to address these questions and here we present a preliminary crystallographic analysis of caZαPKZ in complex with Z-DNA as the first step in the determination of its three-dimensional structure.

2. Materials and methods

2.1. Cloning, expression and purification

The coding sequence of the Zα domain (residues 1–75) of PKZ from C. auratus was cloned into pET28a+ (Novagen, Madison, Wisconsin, USA). As a result, an extra six histidine residues were attached to the N-terminus of caZαPKZ and were subsequently removed during purification. Escherichia coli BL21(DE3) cells (Novagen, Madison, Wisconsin, USA) transformed with this recombinant plasmid were grown in Luria–Bertani medium containing 30 mg ml−1 kanamycin at 310 K and 0.1 mM isopropyl β-d-1-thiogalactoside (IPTG) was added when the OD600 reached 0.6. The cells were harvested after 3 h and caZαPKZ was purified essentially as described elsewhere (Schwartz et al., 1999). Briefly, after initial chromatography on a HiTrap metal-chelating column (GE Healthcare, Princeton, New Jersey, USA), thrombin was added to remove the hexahistidine tag and caZαPKZ was further purified using a Resource S ion-exchange column (GE Healthcare, Princeton, New Jersey, USA). The purified caZαPKZ was dialyzed against buffer A (5 mM HEPES pH 7.5 and 10 mM NaCl) and concentrated to 1 mM. The protein concentration was determined using the Bradford method.

2.2. Preparation of the double-stranded DNA

The double-stranded DNA (dsDNA) was obtained by heating the single-strand oligomer d(TCGCGCG) (Bioneer, Daejeon, Korea) in buffer A for 10 min at 353 K followed by gradual cooling to 277 K. dsDNA was then isolated by MonoQ ion-exchange column chromatography (GE Healthcare, Princeton, New Jersey), dialyzed against distilled water and lyophilized for storage and crystallization. The DNA concentration was calculated by UV spectroscopy.

2.3. Z-DNA conversion assay

The Z-DNA conversion activity of caZαPKZ was measured by circular dichroism (CD) using 30 µM d(TCGCGCG)2 in buffer A. CD spectra were obtained at 298 K using a Jasco J-810 CD spectrometer (Jasco, Tokyo, Japan) and a 0.1 cm quartz cell. The volume of the concentrated caZαPKZ stock solution added to each reaction did not exceed 5% of the total volume. The mixture was equilibrated for 1 h prior to measurement. Spectra were recorded between 240 and 310 nm at 1 nm intervals averaged over 2 s.

2.4. Crystallization

Purified caZαPKZ protein (0.6 mM) was mixed with dsDNA in a 1:2 molar ratio in buffer A and incubated at 303 K for 2 h. Initial crystallization screening was performed manually at 295 K by the microbatch method using Crystal Screens I and II (Hampton Research, Aliso Viejo, California, USA) and Cryo I and II kits (Emerald Biosystems, Bainbridge Island, Washington, USA). Each drop consisting of 1 µl screen solution and 1 µl protein–DNA mixture was covered with 10 µl Al’s Oil (Hampton Research, Aliso Viejo, California) in Nunclon Δ Surface wells (Nunc, Rochester, New York, USA). In order to optimize the initial crystallization conditions, a number of parameters were varied.

2.5. Data collection

Complete diffraction data were collected using a MAR CCD 165 mm detector on the BL4A beamline of the Pohang Accelerator Laboratory Synchrotron (Pohang, Korea) from a crystal that was flash-cooled in a cold nitrogen-gas stream at 100 K. Prior to data collection, the crystal was immersed for more than 30 s in mother liquor (30% PEG 1500, 15 mM MnCl2) containing 25%(v/v) glycerol as a cryoprotectant. The wavelength of the synchrotron radiation was 1.000 Å. The diffraction data were processed and scaled using HKL-2000 (Otwinowski & Minor, 1997).

3. Results and discussion

PKZ from goldfish was expressed in E. coli and purified for structural studies. Approximately 10 mg of homogenous protein was ob­tained per litre of culture. The CD spectrum of the caZαPKZ–d(TCGCGCG)2 mixture indicated a typical Z conformation of the DNA, which confirmed that caZαPKZ is able to convert d(TCG­CGCG)2 to the Z conformation. The CD spectra showing the Z-­DNA conformation were virtually the same when caZαPKZ was added to DNA in a twofold or fourfold molar excess, suggesting that the formation of Z-DNA in the mixture was saturated at a caZαPKZ:d(TCGCGCG)2 ratio of 2:1 (Fig. 1). This finding is consistent with previous structure studies (Schwartz et al., 1999, 2001; Ha et al., 2004) showing that a Z-DNA-binding protein binds to each strand of d(TCGCGCG)2 in the Z conformation.

Figure 1.

Figure 1

The B-DNA to Z-DNA conversion activity of caZαPKZ measured by circular dichroism (CD). caZαPKZ was added to d(TCGCGCG)2 at the indicated molar ratios of 1:1, 2:1 and 4:1 and incubated for 1 h prior to the CD measurement. In the absence of caZαPKZ, the B-DNA spectrum was observed. The conformational change to Z-DNA was monitored by CD spectra between 240 and 310 nm.

In the initial crystallization screen, clusters of needle-shaped crystals of the caZαPKZ–Z-DNA complex were obtained using con­dition No. 43 (30% PEG1500) from Crystal Screen I (Hampton Research, Aliso Viejo, USA; Fig. 2 a). However, the shape and size of these crystals were not suitable for X-ray diffraction experiments. The addition of MnCl2 resulted in a change in crystal shape from clusters of needles to tetragonal columns (Fig. 2 b) and diffraction-quality crystals were finally observed using 30% PEG 1500 and 15 mM MnCl2 at 295 K. The crystals grew to final dimensions of 0.1 × 0.1 × 0.5 mm within 2 d (Fig. 2 b). The presence of DNA in the crystal was confirmed by EtBr staining of the dissolved crystals on 0.8% agarose gel (Fig. 3).

Figure 2.

Figure 2

Crystals of the caZαPKZ–d(TCGCGCG)2 complex. (a) Crystals obtained in the initial screening. (b) Diffraction-quality crystals obtained using the optimized crystallization conditions. The approximate dimensions of the optimized crystals are 0.1 × 0.1 × 0.5 mm.

Figure 3.

Figure 3

Crystals of the caZαPKZ–d(TCGCGCG)2 complex dissolved in 10 µl distilled water were loaded onto a 0.8% agarose gel and stained with EtBr. Lane 1, which contained only protein, did not stain with EtBr. Lane 2, which contained the dissolved crystals, picked up the dye, demonstrating that the crystals contained the protein–DNA complex.

X-ray diffraction data were collected from a cryoprotected crystal to 96.5% completeness at 1.7 Å resolution with an R merge of 7.4%. The crystal belonged to the monoclinic space group C2, with unit-cell parameters a = 55.54, b = 49.93, c = 29.44 Å, β = 96.5°. Assuming the presence of one caZαPKZ molecule and one single-stranded DNA molecule per asymmetric unit, the Matthews coefficient V M was calculated to be 2.01 Å3 Da−1, which corresponds to 45.4% solvent content. This V M value is within the range commonly observed for protein crystals (Matthews, 1968). The data-collection and processing statistics are summarized in Table 1. We intend to solve the structure of caZαPKZ complexed with dsDNA by molecular replacement using the Zα domain of human ADAR1 bound to d(TCGCGCG)2 (PDB code 1qbj) as a template model.

Table 1. X-ray data-collection and processing statistics.

Values in parentheses are for the last shell.

Wavelength (Å) 1.000
Space group C2
Unit-cell parameters (Å, °) a = 55.54, b = 49.93, c = 29.44, β = 96.5
Resolution (Å) 20.0–1.70 (1.76–1.70)
Unique reflections 29661 (8586)
Completeness (%) 96.5 (90.3)
Redundancy 1.9
Rmerge (%) 7.4 (15.4)
I/σ(I)〉 35.9 (7.3)

R merge = Inline graphic Inline graphic.

Acknowledgments

This work was supported by the National Research Laboratory Program (NLR-2006-02287) of the Korea Ministry of Education, Science and Technology.

References

  1. Bergan, V., Jagus, R., Lauksund, S., Kileng, O. & Robertsen, B. (2008). FEBS J.275, 184–197. [DOI] [PubMed]
  2. Garcia, M. A., Meurs, E. F. & Esteban, M. (2007). Biochimie, 89, 799–811. [DOI] [PubMed]
  3. Ha, S. C., Lokanath, N. K., Van Quyen, D., Wu, C. A., Lowenhaupt, K., Rich, A., Kim, Y. G. & Kim, K. K. (2004). Proc. Natl Acad. Sci. USA, 101, 14367–14372. [DOI] [PMC free article] [PubMed]
  4. Herbert, A. & Rich, A. (1999). Genetica, 106, 37–47. [DOI] [PubMed]
  5. Herbert, A. & Rich, A. (2001). Proc. Natl Acad. Sci. USA, 98, 12132–12137. [DOI] [PMC free article] [PubMed]
  6. Hu, C. Y., Zhang, Y. B., Huang, G. P., Zhang, Q. Y. & Gui, J. F. (2004). Fish Shellfish Immunol.17, 353–366. [DOI] [PubMed]
  7. Kim, Y. G., Muralinath, M., Brandt, T., Pearcy, M., Hauns, K., Lowenhaupt, K., Jacobs, B. L. & Rich, A. (2003). Proc. Natl Acad. Sci. USA, 100, 6974–6979. [DOI] [PMC free article] [PubMed]
  8. Liu, L. F. & Wang, J. C. (1987). Proc. Natl Acad. Sci. USA, 84, 7024–7027.
  9. Matthews, B. W. (1968). J. Mol. Biol.33, 491–497. [DOI] [PubMed]
  10. Otwinowski, Z. & Minor, W. (1997). Methods Enzymol.276, 307–326. [DOI] [PubMed]
  11. Proud, C. G. (2005). Semin. Cell Dev. Biol.16, 3–12. [DOI] [PubMed]
  12. Quyen, D. V., Ha, S. C., Lowenhaupt, K., Rich, A., Kim, K. K. & Kim, Y. G. (2007). Nucleic Acids Res.35, 7714–7720. [DOI] [PMC free article] [PubMed]
  13. Rich, A. & Zhang, S. (2003). Nature Rev. Genet.4, 566–572. [DOI] [PubMed]
  14. Rothenburg, S., Deigendesch, N., Dittmar, K., Koch-Nolte, F., Haag, F., Lowenhaupt, K. & Rich, A. (2005). Proc. Natl Acad. Sci. USA, 102, 1602–1607. [DOI] [PMC free article] [PubMed]
  15. Schwartz, T., Behlke, J., Lowenhaupt, K., Heinemann, U. & Rich, A. (2001). Nature Struct. Biol.8, 761–765. [DOI] [PubMed]
  16. Schwartz, T., Rould, M. A., Lowenhaupt, K., Herbert, A. & Rich, A. (1999). Science, 284, 1841–1845. [DOI] [PubMed]
  17. Su, J., Zhu, Z. & Wang, Y. (2008). Fish Shellfish Immunol.25, 106–113. [DOI] [PubMed]
  18. Takaoka, A., Wang, Z., Choi, M. K., Yanai, H., Negishi, H., Ban, T., Lu, Y., Miyagishi, M., Kodama, T., Honda, K., Ohba, Y. & Taniguchi, T. (2007). Nature (London), 448, 501–505. [DOI] [PubMed]
  19. Wang, G., Christensen, L. A. & Vasquez, K. M. (2006). Proc. Natl Acad. Sci. USA, 103, 2677–2682. [DOI] [PMC free article] [PubMed]

Articles from Acta Crystallographica Section F: Structural Biology and Crystallization Communications are provided here courtesy of International Union of Crystallography

RESOURCES